In a recent episode of CNBC’s ‘Mad Money Lightning Round,’ Jim Cramer provided his analysis of several companies, including Target, Zoetis, PROCEPT BioRobotics, and Consolidated Edison.
For Target (TGT), Cramer was enthusiastic about the company’s strong second-quarter results, which surpassed both earnings and sales expectations. He also highlighted the company’s attractive dividend yield of 3%. Target’s impressive performance led to an optimistic revision of its full-year profit outlook.
Cramer also expressed his positive sentiment towards Zoetis (ZTS), an animal health company, praising its strong second-quarter financial results and raised guidance for 2024. Zoetis reported an 8% year-over-year increase in revenue, exceeding market expectations.
When asked about PROCEPT BioRobotics (PRCT), a company focused on robotics for medical procedures, Cramer acknowledged its rapid growth but recommended investors consider Intuitive Surgical (ISRG) instead for their robotics investments.
Finally, Cramer voiced his continued support for Consolidated Edison (ED), praising its steady performance and its attractive dividend yield. He indicated that he has held the stock for a considerable period and remains optimistic about its future prospects.
It’s worth noting that while Cramer offered his opinions on these companies, he does not provide financial advice. Investors should conduct their own thorough research before making any investment decisions.
